arrow
M

Michelle J. Henderson

University of New South Wales
H指数:31
被引数:4,356

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blinatumomab in de novo AYA ALL—Results of the Australasian Leukaemia and Lymphoma Group ALL09 “SUBLIME” study
2026-01-230
OAAI
Measurable residual disease detection in acute lymphoblastic leukaemia: comparison between targeted next-generation sequencing and allele-specific oligonucleotide real-time quantitative polymerase chain reaction

急性淋巴细胞白血病的可测量残留病灶检测:靶向下一代测序与等位基因特异性寡核苷酸实时定量聚合酶链反应的比较

2025-11-250
PRE
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia
2024-11-060
OAAI
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
2024-07-051
OAAI
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
2022-06-015
OA
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression

Curaxin CBL0137和组蛋白去乙酰化酶抑制剂Panobinostat的组合延缓了KMT2A-Rearranged白血病的进展

2022-05-239
OAAI
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma
2021-09-018
OAAI
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma

Curaxin CBL0137和组蛋白去乙酰化酶抑制剂Panobinostat双重靶向染色质稳定性在神经母细胞瘤中显示出显着的临床前疗效

2021-05-1619
OA
Prognostic gene expression signature for high-grade serous ovarian cancer

高级别浆液性卵巢癌的预后基因表达特征

2020-09-0186
OAAI
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis
LEUKEMIA
IF13.4
2020-01-0246
OAAI
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia
LEUKEMIA
IF13.4
2019-12-1720
OAAI
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35
2019-11-0570
OAAI